CDKN2B-AS1 and hepatocellular carcinoma: Furthermore, they highlighted that ANRIL can act as a ceRNA by competitively binding to miR-153-5p, thus increasing ARHGAP18 expression to promote tumorigenesis and metastasis in HCC [52].